SCHEMBL20756286

SCHEMBL20756286

CC1CCCN(c2cc(F)ccc2F)C1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.68
HTT P42858 1/20 0.68
MAPT P10636 5/20 0.56
F2RL1 P55085 2/20 0.46
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 3/20 0.42
ALDH1A1 P00352 4/20 0.42
POLB P06746 1/20 0.42
BLM P54132 1/20 0.41
THRB P10828 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7602459 0.90 HTT (0.55) KDM4EHTTMAPTF2RL1GAA
SCHEMBL20756486 0.81 HTT (0.55) KDM4EHTTMAPTGAASMN1; SMN2
Hydrochloric Acid SCHEMBL29978709 0.81 HTT (1.00) KDM4EHTTMAPTF2RL1GAA
SCHEMBL20756890 0.81 HTT (0.46) KDM4EHTTMAPTF2RL1GAA
Hydrochloric Acid SCHEMBL23043576 0.81 HTT (1.00) KDM4EHTTMAPTF2RL1GAA
SCHEMBL5716060 0.77 ALDH1A1 (0.56) KDM4EHTTMAPTF2RL1GAA
SCHEMBL15383528 0.77 KDM4E (0.57) KDM4EHTTMAPTSMN1; SMN2TP53
SCHEMBL31145170 0.77 KDM4E (0.57) KDM4EHTTMAPTSMN1; SMN2TP53
SCHEMBL28174509 0.77 F2RL1 (0.49) KDM4EHTTMAPTF2RL1GAA
Hydrochloric Acid SCHEMBL15018127 0.76 ALDH1A1 (0.59) KDM4EHTTMAPTF2RL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019036377-A1 TRICYCLIC COMPOUNDS AS HISTONE METHYL-TRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2019-02-21 WO disclosed